Skip to content
DraconiticResearch
Search Sources API
190,851 studies31 sourcesUpdated 51 min ago
Peer-reviewedCC BY-NC-ND 4.0Cell Communication and Signaling

P2X4 receptor prevents adverse remodeling of cardiac tissue after ischemia-reperfusion by controlling autophagy in cardiac fibroblasts

1 more authors

Abstract

Background Pathological ventricular remodeling is an adverse tissue response following acute myocardial infarction (AMI), characterized by an exaggerated fibrosis leading to tissue disorganization and chronic heart failure. Cardiac fibroblasts have a prominent role in the healing process, but also in the fibrosis development, through their differentiation into myofibroblasts, which produce the extracellular matrix, in response to ischemia-reperfusion. Recently, the ATP-gated P2X4 ionotropic receptor has been identified as a key regulator of macro-autophagy, activated under metabolic challenges. MethodsIn this study, we investigated the participation of the P2X4 receptor in the metabolic response of cardiac fibroblasts to ischemia-reperfusion and the myofibroblast switch. To this end, we submitted a primary culture of cardiac fibroblasts to an ischemia-reperfusion simulation and assessed autophagic flux, fibrotic differentiation markers and the correlation to P2X4 expression and activity. Then, using pharmacological inhibition and siRNAmediated knockdown receptor under-expression, we investigated its role in the response of cardiac fibroblasts to this metabolic challenge. Finally, we validated our findings in an in vivo murine model of coronary ligation in wild-type and P2rx4 -/-mice.

ResultsOur results reveal that human cardiac fibroblasts subjected to simulated ischemia present an increased autophagic activity associated with a concomitant overexpression of P2X4 and its activity at the plasma membrane of cells. Pharmacological antagonism of P2X4, or its silencing, impaired autophagy, as evidenced by the accumulation of autophagy markers, and induced the expression of fibrotic markers. In an in vivo model of AMI through transient coronary ligation, P2rx4 -/-mice presented the accumulation of autophagic markers both in healthy and ischemic zones, an extended tissue inflammation and fibrosis compared to wild type mice.

ConclusionsThis study suggests, for the first time, that the P2X4 receptor may contribute to steering cardiac fibroblasts toward a healing-associated profile under ischemia-reperfusion conditions, possibly by modulating autophagic activity and limiting extensive pro-fibrotic differentiation.

Related

  1. Immune–fibroblast ligand–receptor axes in post-infarction cardiac remodeling: convergent and divergent mechanisms compared with cancer-associated fibroblasts
    Hong Lu, Xiao-long Tao, Ding-ming Song +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Cardiovascular medicineCrossref
  2. ACSS2 phosphorylation at Ser659 attenuates neuronal apoptosis induced by cerebral ischemia-reperfusion by initiating autophagy
    Aman Hadierbieke, Amina Buerlike, Haicheng Xia
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthCrossref
  3. Reperfusion duration distinctively alters apoptosis, necroptosis, ferroptosis, pyroptosis, and autophagy markers during early reperfusion in isolated rat hearts
    Valeria C. Villarín-Ayala, Josh Dávila-Matos, Jorge García-Báez +4
    Scientific ReportsPeer-reviewedCC BY 4.0Full textGeneral medicineCrossref
  4. Esketamine exerts a protective effect against skeletal muscle injury induced by hindlimb ischemia-reperfusion in mice by regulating autophagy
    Jingwang Liu, Jiaxin Liu, Tianyi He +7
    PLOS OnePeer-reviewedCC BY 4.0Full textPhysiologyPLOS
  5. Estradiol deficiency aggravates AngII-induced vascular remodeling by failing to inhibit GRK2 through ERα-mediated autophagy
    Miao-Jin Ji, Ni-na Song, Joseph Adu-Amankwaah +7
    Communications BiologyPeer-reviewedCC BY-NC-ND 4.0Full textCardiovascular medicineCrossref
BibTeX
@article{silva2026p2x4,
  title = {{P2X4 receptor prevents adverse remodeling of cardiac tissue after ischemia-reperfusion by controlling autophagy in cardiac fibroblasts}},
  author = {Ana Valeria Vinhais da Silva and Juliette Strella and Simon Chesseron and Arthur Aupart and Audrey Heraud-Meley and Elodie Miquelestorena-Standley and Marc Ohresser and Ludovica Congiu and Eric Boué-Grabot and Thierry Bourguignon and Sébastien Roger and Stephanie Chadet and Fabrice Ivanes},
  journal = {Cell Communication and Signaling},
  year = {2026},
  month = jul,
  doi = {10.1186/s12964-026-03050-4},
  url = {https://hal.science/hal-05794031v1},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - P2X4 receptor prevents adverse remodeling of cardiac tissue after ischemia-reperfusion by controlling autophagy in cardiac fibroblasts
AU  - Ana Valeria Vinhais da Silva
AU  - Juliette Strella
AU  - Simon Chesseron
AU  - Arthur Aupart
AU  - Audrey Heraud-Meley
AU  - Elodie Miquelestorena-Standley
AU  - Marc Ohresser
AU  - Ludovica Congiu
AU  - Eric Boué-Grabot
AU  - Thierry Bourguignon
AU  - Sébastien Roger
AU  - Stephanie Chadet
AU  - Fabrice Ivanes
PY  - 2026
DA  - 2026/07/10
JO  - Cell Communication and Signaling
DO  - 10.1186/s12964-026-03050-4
UR  - https://hal.science/hal-05794031v1
AB  - Background Pathological ventricular remodeling is an adverse tissue response following acute myocardial infarction (AMI), characterized by an exaggerated fibrosis leading to tissue disorganization and chronic heart failure. Cardiac fibroblasts have a prominent role in the healing process, but also in the fibrosis development, through their differentiation into myofibroblasts, which produce the extracellular matrix, in response to ischemia-reperfusion. Recently, the ATP-gated P2X4 ionotropic receptor has been identified as a key regulator of macro-autophagy, activated under metabolic challenges. MethodsIn this study, we investigated the participation of the P2X4 receptor in the metabolic response of cardiac fibroblasts to ischemia-reperfusion and the myofibroblast switch. To this end, we submitted a primary culture of cardiac fibroblasts to an ischemia-reperfusion simulation and assessed autophagic flux, fibrotic differentiation markers and the correlation to P2X4 expression and activity. Then, using pharmacological inhibition and siRNAmediated knockdown receptor under-expression, we investigated its role in the response of cardiac fibroblasts to this metabolic challenge. Finally, we validated our findings in an in vivo murine model of coronary ligation in wild-type and P2rx4 -/-mice.  ResultsOur results reveal that human cardiac fibroblasts subjected to simulated ischemia present an increased autophagic activity associated with a concomitant overexpression of P2X4 and its activity at the plasma membrane of cells. Pharmacological antagonism of P2X4, or its silencing, impaired autophagy, as evidenced by the accumulation of autophagy markers, and induced the expression of fibrotic markers. In an in vivo model of AMI through transient coronary ligation, P2rx4 -/-mice presented the accumulation of autophagic markers both in healthy and ischemic zones, an extended tissue inflammation and fibrosis compared to wild type mice.  ConclusionsThis study suggests, for the first time, that the P2X4 receptor may contribute to steering cardiac fibroblasts toward a healing-associated profile under ischemia-reperfusion conditions, possibly by modulating autophagic activity and limiting extensive pro-fibrotic differentiation.
SN  - 1478-811X
ER  -